世界の個別化医療におけるナノ材料市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Nanomaterials in Personalized Medicine Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A14059 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、個別化医療におけるナノ材料のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。個別化医療におけるナノ材料の種類別市場規模（ナノメディシン、ナノメートル医療機器、その他）、用途別市場規模（抗がん剤、CNS製品、抗感染症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・個別化医療におけるナノ材料の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott、Amgen、Biogen、Celgene、Gilead Sciences、Merck and Co、Pfizer、Roche、Sanofi、Stryker、Teva Pharmaceuticals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ナノメディシン、ナノメートル医療機器、その他 ・用途別分析2016年-2026年：抗がん剤、CNS製品、抗感染症、その他 ・個別化医療におけるナノ材料の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・個別化医療におけるナノ材料のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・個別化医療におけるナノ材料のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・個別化医療におけるナノ材料の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・個別化医療におけるナノ材料の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Nanomaterials in Personalized Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Nanomaterials in Personalized Medicine size is estimated to be USD XX million in 2026 from USD XX million in 2020, with a change XX% between 2020 and 2021. The global Nanomaterials in Personalized Medicine market size is expected to grow at a CAGR of XX% for the next five years.

Market segmentation
Nanomaterials in Personalized Medicine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Nano-Medicine
Nanometer Medical Instrument
Others

Market segment by Application, can be divided into
Anticancer
CNS Products
Anti-infection
Others

Market segment by players, this report covers
Abbott
Amgen
Biogen
Celgene
Gilead Sciences
Merck and Co
Pfizer
Roche
Sanofi
Stryker
Teva Pharmaceuticals

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Nanomaterials in Personalized Medicine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Nanomaterials in Personalized Medicine, with revenue, gross margin and global market share of Nanomaterials in Personalized Medicine from 2019 to 2021.
Chapter 3, the Nanomaterials in Personalized Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Nanomaterials in Personalized Medicine market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Nanomaterials in Personalized Medicine research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Nanomaterials in Personalized Medicine
1.2 Classification of Nanomaterials in Personalized Medicine by Type
1.2.1 Overview: Global Nanomaterials in Personalized Medicine Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Nanomaterials in Personalized Medicine Revenue Market Share by Type in 2020
1.2.3 Nano-Medicine
1.2.4 Nanometer Medical Instrument
1.2.5 Others
1.3 Global Nanomaterials in Personalized Medicine Market by Application
1.3.1 Overview: Global Nanomaterials in Personalized Medicine Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Anticancer
1.3.3 CNS Products
1.3.4 Anti-infection
1.3.5 Others
1.4 Global Nanomaterials in Personalized Medicine Market Size & Forecast
1.5 Global Nanomaterials in Personalized Medicine Market Size and Forecast by Region
1.5.1 Global Nanomaterials in Personalized Medicine Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Nanomaterials in Personalized Medicine Market Size by Region, (2016-2021)
1.5.3 North America Nanomaterials in Personalized Medicine Market Size and Prospect (2016-2026)
1.5.4 Europe Nanomaterials in Personalized Medicine Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Nanomaterials in Personalized Medicine Market Size and Prospect (2016-2026)
1.5.6 South America Nanomaterials in Personalized Medicine Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Nanomaterials in Personalized Medicine Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Nanomaterials in Personalized Medicine Market Drivers
1.6.2 Nanomaterials in Personalized Medicine Market Restraints
1.6.3 Nanomaterials in Personalized Medicine Trends Analysis
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Nanomaterials in Personalized Medicine Product and Solutions
2.1.4 Abbott Nanomaterials in Personalized Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Nanomaterials in Personalized Medicine Product and Solutions
2.2.4 Amgen Nanomaterials in Personalized Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Amgen Recent Developments and Future Plans
2.3 Biogen
2.3.1 Biogen Details
2.3.2 Biogen Major Business
2.3.3 Biogen Nanomaterials in Personalized Medicine Product and Solutions
2.3.4 Biogen Nanomaterials in Personalized Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Biogen Recent Developments and Future Plans
2.4 Celgene
2.4.1 Celgene Details
2.4.2 Celgene Major Business
2.4.3 Celgene Nanomaterials in Personalized Medicine Product and Solutions
2.4.4 Celgene Nanomaterials in Personalized Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Celgene Recent Developments and Future Plans
2.5 Gilead Sciences
2.5.1 Gilead Sciences Details
2.5.2 Gilead Sciences Major Business
2.5.3 Gilead Sciences Nanomaterials in Personalized Medicine Product and Solutions
2.5.4 Gilead Sciences Nanomaterials in Personalized Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Gilead Sciences Recent Developments and Future Plans
2.6 Merck and Co
2.6.1 Merck and Co Details
2.6.2 Merck and Co Major Business
2.6.3 Merck and Co Nanomaterials in Personalized Medicine Product and Solutions
2.6.4 Merck and Co Nanomaterials in Personalized Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Merck and Co Recent Developments and Future Plans
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Nanomaterials in Personalized Medicine Product and Solutions
2.7.4 Pfizer Nanomaterials in Personalized Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Pfizer Recent Developments and Future Plans
2.8 Roche
2.8.1 Roche Details
2.8.2 Roche Major Business
2.8.3 Roche Nanomaterials in Personalized Medicine Product and Solutions
2.8.4 Roche Nanomaterials in Personalized Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Roche Recent Developments and Future Plans
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Nanomaterials in Personalized Medicine Product and Solutions
2.9.4 Sanofi Nanomaterials in Personalized Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Sanofi Recent Developments and Future Plans
2.10 Stryker
2.10.1 Stryker Details
2.10.2 Stryker Major Business
2.10.3 Stryker Nanomaterials in Personalized Medicine Product and Solutions
2.10.4 Stryker Nanomaterials in Personalized Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Stryker Recent Developments and Future Plans
2.11 Teva Pharmaceuticals
2.11.1 Teva Pharmaceuticals Details
2.11.2 Teva Pharmaceuticals Major Business
2.11.3 Teva Pharmaceuticals Nanomaterials in Personalized Medicine Product and Solutions
2.11.4 Teva Pharmaceuticals Nanomaterials in Personalized Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Teva Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Nanomaterials in Personalized Medicine Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Nanomaterials in Personalized Medicine Players Market Share
3.2.2 Top 10 Nanomaterials in Personalized Medicine Players Market Share
3.2.3 Market Competition Trend
3.3 Nanomaterials in Personalized Medicine Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Nanomaterials in Personalized Medicine Revenue and Market Share by Type (2016-2021)
4.2 Global Nanomaterials in Personalized Medicine Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Nanomaterials in Personalized Medicine Revenue Market Share by Application (2016-2021)
5.2 Nanomaterials in Personalized Medicine Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Nanomaterials in Personalized Medicine Revenue by Type (2016-2026)
6.2 North America Nanomaterials in Personalized Medicine Revenue by Application (2016-2026)
6.3 North America Nanomaterials in Personalized Medicine Market Size by Country
6.3.1 North America Nanomaterials in Personalized Medicine Revenue by Country (2016-2026)
6.3.2 United States Nanomaterials in Personalized Medicine Market Size and Forecast (2016-2026)
6.3.3 Canada Nanomaterials in Personalized Medicine Market Size and Forecast (2016-2026)
6.3.4 Mexico Nanomaterials in Personalized Medicine Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Nanomaterials in Personalized Medicine Revenue by Type (2016-2026)
7.2 Europe Nanomaterials in Personalized Medicine Revenue by Application (2016-2026)
7.3 Europe Nanomaterials in Personalized Medicine Market Size by Country
7.3.1 Europe Nanomaterials in Personalized Medicine Revenue by Country (2016-2026)
7.3.2 Germany Nanomaterials in Personalized Medicine Market Size and Forecast (2016-2026)
7.3.3 France Nanomaterials in Personalized Medicine Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Nanomaterials in Personalized Medicine Market Size and Forecast (2016-2026)
7.3.5 Russia Nanomaterials in Personalized Medicine Market Size and Forecast (2016-2026)
7.3.6 Italy Nanomaterials in Personalized Medicine Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Nanomaterials in Personalized Medicine Revenue by Type (2016-2026)
8.2 Asia-Pacific Nanomaterials in Personalized Medicine Revenue by Application (2016-2026)
8.3 Asia-Pacific Nanomaterials in Personalized Medicine Market Size by Region
8.3.1 Asia-Pacific Nanomaterials in Personalized Medicine Revenue by Region (2016-2026)
8.3.2 China Nanomaterials in Personalized Medicine Market Size and Forecast (2016-2026)
8.3.3 Japan Nanomaterials in Personalized Medicine Market Size and Forecast (2016-2026)
8.3.4 South Korea Nanomaterials in Personalized Medicine Market Size and Forecast (2016-2026)
8.3.5 India Nanomaterials in Personalized Medicine Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Nanomaterials in Personalized Medicine Market Size and Forecast (2016-2026)
8.3.7 Australia Nanomaterials in Personalized Medicine Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Nanomaterials in Personalized Medicine Revenue by Type (2016-2026)
9.2 South America Nanomaterials in Personalized Medicine Revenue by Application (2016-2026)
9.3 South America Nanomaterials in Personalized Medicine Market Size by Country
9.3.1 South America Nanomaterials in Personalized Medicine Revenue by Country (2016-2026)
9.3.2 Brazil Nanomaterials in Personalized Medicine Market Size and Forecast (2016-2026)
9.3.3 Argentina Nanomaterials in Personalized Medicine Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Nanomaterials in Personalized Medicine Revenue by Type (2016-2026)
10.2 Middle East & Africa Nanomaterials in Personalized Medicine Revenue by Application (2016-2026)
10.3 Middle East & Africa Nanomaterials in Personalized Medicine Market Size by Country
10.3.1 Middle East & Africa Nanomaterials in Personalized Medicine Revenue by Country (2016-2026)
10.3.2 Turkey Nanomaterials in Personalized Medicine Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Nanomaterials in Personalized Medicine Market Size and Forecast (2016-2026)
10.3.4 UAE Nanomaterials in Personalized Medicine Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Nanomaterials in Personalized Medicine Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Nanomaterials in Personalized Medicine Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Nanomaterials in Personalized Medicine Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Nanomaterials in Personalized Medicine Revenue (USD Million) by Region (2016-2021)
Table 5. Global Nanomaterials in Personalized Medicine Revenue Market Share by Region (2021-2026)
Table 6. Abbott Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Major Business
Table 8. Abbott Nanomaterials in Personalized Medicine Product and Solutions
Table 9. Abbott Nanomaterials in Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Amgen Corporate Information, Head Office, and Major Competitors
Table 11. Amgen Major Business
Table 12. Amgen Nanomaterials in Personalized Medicine Product and Solutions
Table 13. Amgen Nanomaterials in Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Biogen Corporate Information, Head Office, and Major Competitors
Table 15. Biogen Major Business
Table 16. Biogen Nanomaterials in Personalized Medicine Product and Solutions
Table 17. Biogen Nanomaterials in Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Celgene Corporate Information, Head Office, and Major Competitors
Table 19. Celgene Major Business
Table 20. Celgene Nanomaterials in Personalized Medicine Product and Solutions
Table 21. Celgene Nanomaterials in Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Gilead Sciences Corporate Information, Head Office, and Major Competitors
Table 23. Gilead Sciences Major Business
Table 24. Gilead Sciences Nanomaterials in Personalized Medicine Product and Solutions
Table 25. Gilead Sciences Nanomaterials in Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Merck and Co Corporate Information, Head Office, and Major Competitors
Table 27. Merck and Co Major Business
Table 28. Merck and Co Nanomaterials in Personalized Medicine Product and Solutions
Table 29. Merck and Co Nanomaterials in Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Pfizer Corporate Information, Head Office, and Major Competitors
Table 31. Pfizer Major Business
Table 32. Pfizer Nanomaterials in Personalized Medicine Product and Solutions
Table 33. Pfizer Nanomaterials in Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Roche Corporate Information, Head Office, and Major Competitors
Table 35. Roche Major Business
Table 36. Roche Nanomaterials in Personalized Medicine Product and Solutions
Table 37. Roche Nanomaterials in Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Sanofi Corporate Information, Head Office, and Major Competitors
Table 39. Sanofi Major Business
Table 40. Sanofi Nanomaterials in Personalized Medicine Product and Solutions
Table 41. Sanofi Nanomaterials in Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Stryker Corporate Information, Head Office, and Major Competitors
Table 43. Stryker Major Business
Table 44. Stryker Nanomaterials in Personalized Medicine Product and Solutions
Table 45. Stryker Nanomaterials in Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Teva Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 47. Teva Pharmaceuticals Major Business
Table 48. Teva Pharmaceuticals Nanomaterials in Personalized Medicine Product and Solutions
Table 49. Teva Pharmaceuticals Nanomaterials in Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Global Nanomaterials in Personalized Medicine Revenue (USD Million) by Players (2019-2021)
Table 51. Global Nanomaterials in Personalized Medicine Revenue Share by Players (2019-2021)
Table 52. Breakdown of Nanomaterials in Personalized Medicine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Nanomaterials in Personalized Medicine Players Head Office, Products and Services Provided
Table 54. Nanomaterials in Personalized Medicine Mergers & Acquisitions in the Past Five Years
Table 55. Nanomaterials in Personalized Medicine New Entrants and Expansion Plans
Table 56. Global Nanomaterials in Personalized Medicine Revenue (USD Million) by Type (2016-2021)
Table 57. Global Nanomaterials in Personalized Medicine Revenue Share by Type (2016-2021)
Table 58. Global Nanomaterials in Personalized Medicine Revenue Forecast by Type (2021-2026)
Table 59. Global Nanomaterials in Personalized Medicine Revenue by Application (2016-2021)
Table 60. Global Nanomaterials in Personalized Medicine Revenue Forecast by Application (2021-2026)
Table 61. North America Nanomaterials in Personalized Medicine Revenue by Type (2016-2021) & (USD Million)
Table 62. North America Nanomaterials in Personalized Medicine Revenue by Type (2021-2026) & (USD Million)
Table 63. North America Nanomaterials in Personalized Medicine Revenue by Application (2016-2021) & (USD Million)
Table 64. North America Nanomaterials in Personalized Medicine Revenue by Application (2021-2026) & (USD Million)
Table 65. North America Nanomaterials in Personalized Medicine Revenue by Country (2016-2021) & (USD Million)
Table 66. North America Nanomaterials in Personalized Medicine Revenue by Country (2021-2026) & (USD Million)
Table 67. Europe Nanomaterials in Personalized Medicine Revenue by Type (2016-2021) & (USD Million)
Table 68. Europe Nanomaterials in Personalized Medicine Revenue by Type (2021-2026) & (USD Million)
Table 69. Europe Nanomaterials in Personalized Medicine Revenue by Application (2016-2021) & (USD Million)
Table 70. Europe Nanomaterials in Personalized Medicine Revenue by Application (2021-2026) & (USD Million)
Table 71. Europe Nanomaterials in Personalized Medicine Revenue by Country (2016-2021) & (USD Million)
Table 72. Europe Nanomaterials in Personalized Medicine Revenue by Country (2021-2026) & (USD Million)
Table 73. Asia-Pacific Nanomaterials in Personalized Medicine Revenue by Type (2016-2021) & (USD Million)
Table 74. Asia-Pacific Nanomaterials in Personalized Medicine Revenue by Type (2021-2026) & (USD Million)
Table 75. Asia-Pacific Nanomaterials in Personalized Medicine Revenue by Application (2016-2021) & (USD Million)
Table 76. Asia-Pacific Nanomaterials in Personalized Medicine Revenue by Application (2021-2026) & (USD Million)
Table 77. Asia-Pacific Nanomaterials in Personalized Medicine Revenue by Region (2016-2021) & (USD Million)
Table 78. Asia-Pacific Nanomaterials in Personalized Medicine Revenue by Region (2021-2026) & (USD Million)
Table 79. South America Nanomaterials in Personalized Medicine Revenue by Type (2016-2021) & (USD Million)
Table 80. South America Nanomaterials in Personalized Medicine Revenue by Type (2021-2026) & (USD Million)
Table 81. South America Nanomaterials in Personalized Medicine Revenue by Application (2016-2021) & (USD Million)
Table 82. South America Nanomaterials in Personalized Medicine Revenue by Application (2021-2026) & (USD Million)
Table 83. South America Nanomaterials in Personalized Medicine Revenue by Country (2016-2021) & (USD Million)
Table 84. South America Nanomaterials in Personalized Medicine Revenue by Country (2021-2026) & (USD Million)
Table 85. Middle East & Africa Nanomaterials in Personalized Medicine Revenue by Type (2016-2021) & (USD Million)
Table 86. Middle East & Africa Nanomaterials in Personalized Medicine Revenue by Type (2021-2026) & (USD Million)
Table 87. Middle East & Africa Nanomaterials in Personalized Medicine Revenue by Application (2016-2021) & (USD Million)
Table 88. Middle East & Africa Nanomaterials in Personalized Medicine Revenue by Application (2021-2026) & (USD Million)
Table 89. Middle East & Africa Nanomaterials in Personalized Medicine Revenue by Country (2016-2021) & (USD Million)
Table 90. Middle East & Africa Nanomaterials in Personalized Medicine Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Nanomaterials in Personalized Medicine Picture
Figure 2. Global Nanomaterials in Personalized Medicine Revenue Market Share by Type in 2020
Figure 3. Nano-Medicine
Figure 4. Nanometer Medical Instrument
Figure 5. Others
Figure 6. Nanomaterials in Personalized Medicine Revenue Market Share by Application in 2020
Figure 7. Anticancer Picture
Figure 8. CNS Products Picture
Figure 9. Anti-infection Picture
Figure 10. Others Picture
Figure 11. Global Nanomaterials in Personalized Medicine Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Nanomaterials in Personalized Medicine Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Nanomaterials in Personalized Medicine Revenue Market Share by Region (2016-2026)
Figure 14. Global Nanomaterials in Personalized Medicine Revenue Market Share by Region in 2020
Figure 15. North America Nanomaterials in Personalized Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Nanomaterials in Personalized Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Nanomaterials in Personalized Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Nanomaterials in Personalized Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Nanomaterials in Personalized Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Nanomaterials in Personalized Medicine Market Drivers
Figure 21. Nanomaterials in Personalized Medicine Market Restraints
Figure 22. Nanomaterials in Personalized Medicine Market Trends
Figure 23. Abbott Recent Developments and Future Plans
Figure 24. Amgen Recent Developments and Future Plans
Figure 25. Biogen Recent Developments and Future Plans
Figure 26. Celgene Recent Developments and Future Plans
Figure 27. Gilead Sciences Recent Developments and Future Plans
Figure 28. Merck and Co Recent Developments and Future Plans
Figure 29. Pfizer Recent Developments and Future Plans
Figure 30. Roche Recent Developments and Future Plans
Figure 31. Sanofi Recent Developments and Future Plans
Figure 32. Stryker Recent Developments and Future Plans
Figure 33. Teva Pharmaceuticals Recent Developments and Future Plans
Figure 34. Global Nanomaterials in Personalized Medicine Revenue Share by Players in 2020
Figure 35. Nanomaterials in Personalized Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players Nanomaterials in Personalized Medicine Revenue Market Share in 2020
Figure 37. Global Top 10 Players Nanomaterials in Personalized Medicine Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global Nanomaterials in Personalized Medicine Revenue Share by Type in 2020
Figure 40. Global Nanomaterials in Personalized Medicine Market Share Forecast by Type (2021-2026)
Figure 41. Global Nanomaterials in Personalized Medicine Revenue Share by Application in 2020
Figure 42. Global Nanomaterials in Personalized Medicine Market Share Forecast by Application (2021-2026)
Figure 43. North America Nanomaterials in Personalized Medicine Sales Market Share by Type (2016-2026)
Figure 44. North America Nanomaterials in Personalized Medicine Sales Market Share by Application (2016-2026)
Figure 45. North America Nanomaterials in Personalized Medicine Revenue Market Share by Country (2016-2026)
Figure 46. United States Nanomaterials in Personalized Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Nanomaterials in Personalized Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Nanomaterials in Personalized Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Nanomaterials in Personalized Medicine Sales Market Share by Type (2016-2026)
Figure 50. Europe Nanomaterials in Personalized Medicine Sales Market Share by Application (2016-2026)
Figure 51. Europe Nanomaterials in Personalized Medicine Revenue Market Share by Country (2016-2026)
Figure 52. Germany Nanomaterials in Personalized Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Nanomaterials in Personalized Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Nanomaterials in Personalized Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Nanomaterials in Personalized Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Nanomaterials in Personalized Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Nanomaterials in Personalized Medicine Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific Nanomaterials in Personalized Medicine Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Nanomaterials in Personalized Medicine Revenue Market Share by Region (2016-2026)
Figure 60. China Nanomaterials in Personalized Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Nanomaterials in Personalized Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea Nanomaterials in Personalized Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Nanomaterials in Personalized Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Nanomaterials in Personalized Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Nanomaterials in Personalized Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Nanomaterials in Personalized Medicine Sales Market Share by Type (2016-2026)
Figure 67. South America Nanomaterials in Personalized Medicine Sales Market Share by Application (2016-2026)
Figure 68. South America Nanomaterials in Personalized Medicine Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Nanomaterials in Personalized Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Nanomaterials in Personalized Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa Nanomaterials in Personalized Medicine Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa Nanomaterials in Personalized Medicine Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa Nanomaterials in Personalized Medicine Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Nanomaterials in Personalized Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Nanomaterials in Personalized Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE Nanomaterials in Personalized Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source

---